Bioventix (LON:BVXP) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Bioventix PLC (LON:BVXP) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 3,865.74 ($47.30) and traded as low as GBX 3,050 ($37.32). Bioventix shares last traded at GBX 3,250 ($39.77), with a volume of 4,369 shares changing hands.

Bioventix Trading Down 4.3 %

The stock has a market capitalization of £162.34 million, a price-to-earnings ratio of 1,907.98 and a beta of 0.35. The firm has a 50-day moving average of GBX 3,505.18 and a 200-day moving average of GBX 3,865.74.

Bioventix Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were given a dividend of GBX 87 ($1.06) per share. This is an increase from Bioventix’s previous dividend of $68.00. This represents a yield of 2.4%. The ex-dividend date was Thursday, November 7th. Bioventix’s dividend payout ratio (DPR) is currently 9,693.25%.

Insiders Place Their Bets

In related news, insider Bruce Hiscock purchased 24 shares of the business’s stock in a transaction on Friday, November 22nd. The shares were bought at an average cost of GBX 3,822 ($46.76) per share, with a total value of £917.28 ($1,122.33). In the last three months, insiders have purchased 385 shares of company stock valued at $1,107,381. Company insiders own 8.02% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.